GDC-1261 clinical trials

A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer

This study is testing a new drug called GDC-1261 for men with advanced prostate cancer that has spread. We want to see if it's safe, how it works in the body, and if it shows early signs of helping. The aim is to find the best dose for future research.